LEGN compared with AVBP: revenue, margins and what each company keeps, and the suppliers and customers both name

LEGNLegend Biotech Corp

Mkt capRevenueRevenue

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

Compare

LEGNLegend Biotech Corp

AVBPArriVent BioPharma, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

LEGN

No earnings history for LEGN.

AVBP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.3%▼−4.64%×0.28

May 12 '26±11.3%▼−0.17%×0.02

Q1 FY26±25.8%▼−7.21%×0.28

Nov 10 '25±21.0%▲+3.08%×0.15

= impliedLEGN realized, solidAVBP realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

LEGNLegend Biotech Corp

21.63▼−3.03%· post 21.63

Mkt cap$4.0B

AVBPArriVent BioPharma, Inc.

14.93▼−6.41%· post 14.72

ClosedOct 30 '26

Mkt cap$707.9M

Compare

ClosedOct 30 '26

LEGNLegend Biotech Corp

AVBPArriVent BioPharma, Inc.

21.63▼−3.03%post 21.63

Price

14.93▼−6.41%post 14.72

$4.0B

Mkt cap

$707.9M

LEGN21.63▼−3.03%vsAVBP14.93▼−6.41%ClosedOct 30 '26